Abstract
A transient transfection process was established using a novel 'in-house' developed transfection reagent, Ro-1539. It allows rapid production of large quantities of various recombinant proteins. Here we describe the transient expression of the secreted human placental alkaline phosphatase (SEAP) by HEK293EBNA and CHO cells in serum-free suspension culture. Unexpectedly, high expression levels of SEAP (150 μg/ml) were found 3–4 days post-transfection when placental alkaline phosphatase (AP) was used as the reference enzyme. To confirm these data, an SDS–PAGE analysis was performed and the visible SEAP protein band (MW of 65 kDa) was compared with co-migrated purified placental AP protein as reference. The scanning analysis of the gel showed that SEAP, a truncated form of AP, has a higher specific activity than the purified placental AP. A correction factor was introduced permitting a direct comparison of placental AP activity with the expression levels of SEAP. Scale-up of the transfection system from spinner flask to bioreactor was simple and straightforward, resulting in similar yields of SEAP. Finally, the effectiveness of Ro-1539 was compared to that of other transfection reagents.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baker E.A., Vaughn M.W. and Haviland D.L. 2000. Choices in transfection methodologies. Focus 22: 31–33.
Berger J., Hauber J., Hauber R., Gelger R. and Cullen B.R. 1988. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66: 1–10.
Boulikas T. 1998. Status of gene therapy in 1997: molecular mechanisms, disease targets, and clinical applications. Gene Ther. Mol. Biol. 1: 1–172.
Bronstein I., Fortin J., Stanley P.E., Stewart G.S.A.B. and Kricka L.J. 1994. Chemiluminescent and bioluminescent reporter gene assays. Anal. Biochem. 219: 169–181.
Chadd H.E. and Chamow S.T. 2001. Therapeutic antibody expression technology. Curr. Opin. Biotechnol. 12: 188–194.
Cullen B.R. and Malim M.H. 1992. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol. 216: 362–368.
Davis C.G., Gallo M.L. and Corvalan J.R.F. 1999. Transgenic mice as a source of fully human antibodies for the treatment of cancer. Cancer Metastasis Rev. 18: 421–425.
Doebeli H., Gentz R., Jucker W., Garotta G., Hartmann W.D. and Hochuli E. 1988. Role of the carboxy-terminal sequence immune interferon (IFN-γ) on the biological activity of human. J. Biotechnol. 7: 199–211.
Durocher Y., Perret S., Thibaudeau E., Gaumond M.H., Kamen A., Stocco R. et al. 2000. A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293EBNA cells grown in suspension culture. Anal. Biochem. 284: 316–326.
Kain S.R. and Ganguly S. 1996. Use of secreted alkaline phosphatase as a reporter of gene expression in mammalian cells. In: Methods in Molecular Biology Vol. vol. 63. Humana Press, Totowa, NJ.
Ledley F.D. 1995. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6: 1129–1144.
Legendre J.Y., Trzeciak A., Bohrmann B., Deuschle U., Kitas E.A. and Supersaxo A. 1996. Dioleoylmelittin as a novel serum insensitive reagent for efficient transfection of mammalian cells. Bioconjug. Chem. 8: 57–63.
Mutel V., Ellis G.J., Adam G., Klingelschmidt A., Messer A., Schlaeger E.-J. et al. 2000. Characterization of [3H]-quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors as well as rat and human brain sections. J. Neurochem. 75: 2590–2601.
Padmaja J., Satyanarayana V. and Merrifield R.B. 1996. Synthetic mellitin, its enantio, retro, and retroenantio isomers, and selected chimeric analogs: their antibacterial, hemolytic, and lipid bilayer action. J. Am. Chem. Soc. 118: 8989–8997.
Schlaeger E.-J. 1996. The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promotor of mammalian cell culture in serum-containing and in serum-free media and displays anti-apoptosis properties. J. Immunol. Methods 194: 191–199.
Schlaeger E.-J. and Christensen K. 1999. Transient gene expression in mammalian cells grown in serum-free suspension culture. Cytotechnology 30: 71–83.
Schlaeger E.-J., Christensen K. and Kitas E.A. 1999. (tiScale-up of transient gene expression in mammalian cells grown in serum free suspension culture. 4th Gene Delivery and Cellular Protein Expression Conference. October 17–21. Lake Tahoe, California.
Schlaeger E.-J. 2000. (tiOptimal transfection complex formation depends on the medium compositions. First European Technology Workshop. October 1–3. Karthause Ittingen, Switzerland.
Schumpp B. and Schlaeger E.-J. 1990. Optimization of culture conditions for high cell density proliferation of HL60 human promyelocytic leukemia cells. J. Cell Sci. 97: 639–647.
Yoon K., Thiede M.A. and Rodan G.A. 1988. Alkaline phosphatase as a reporter enzyme. Gene 66: 11–17.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schlaeger, EJ., Kitas, E.A. & Dorn, A. SEAP expression in transiently transfected mammalian cells grown in serum-free suspension culture. Cytotechnology 42, 47–55 (2003). https://doi.org/10.1023/A:1026125016602
Issue Date:
DOI: https://doi.org/10.1023/A:1026125016602